Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
24,316 total articles
Emergent BioSolutions Inc. announced its Q1 2026 financial results, reporting total revenues of $156.1 million, net income of $6.8 million, and adjusted EBITDA of $35.6 million. While revenues exceeded guidance, they declined 30% year-over-year, driven by lower sales in key biodefense medical countermeasure segments. The company secured new partner…
Home Federal Bancorp, Inc. of Louisiana reported significant increases in net income and earnings per share for the three and nine months ended March 31, 2026, driven by improved net interest margins, increased net interest income, and decreased non-interest expenses. The company also expanded its assets and deposits, while continuing its stock rep…
Cue Biopharma announced a $30 million private placement (PIPE financing) through the sale of pre-funded warrants and common stock warrants, aimed at advancing its clinical pipeline, including the development of Ascendant-221, as well as supporting working capital and general corporate purposes. The financing is expected to close in early May 2026, …
Canadian National Railway Company (CN) issued a statement opposing the amended merger application of Union Pacific and Norfolk Southern, arguing that it fails to adequately address the competitive harms posed by the merger and lacks meaningful remedies as required by the Surface Transportation Board. CN emphasizes the need for strict regulatory con…
HCW Biologics Inc. announced the adjournment of its Special Meeting of Stockholders held on April 27, 2026, due to insufficient quorum, postponing the approval of proposals regarding warrants issued to Armistice Capital Master Fund Ltd. The matters will be addressed at the Annual Meeting scheduled for June 15, 2026. This ongoing delay obliges the c…
Tejon Ranch Co., a diversified real estate development and agribusiness company, announced it will release its Q1 2026 financial results before market open on May 7, 2026, followed by a conference call with executives to discuss recent initiatives and results. The call will be webcast and accessible to investors with Q&A submitted in advance.
Evolution Petroleum Corporation announced its plan to release the fiscal third quarter 2026 financial and operating results on May 12, 2026, followed by a conference call with top executives on May 13, 2026. The company focuses on U.S. onshore oil and natural gas properties, aiming to maximize shareholder returns through diversified asset managemen…
The Boston Beer Company reported first quarter 2026 results showing a 4% decline in depletions and 6.9% decrease in shipments, with net revenue down 4.4%. Despite gross margin improving 100 basis points to 49.3%, the company incurred a substantial non-recurring pre-tax litigation expense of $216 million, resulting in a GAAP diluted loss per share o…
Ryman Hospitality Properties, Inc. (NYSE: RHP) announced record first quarter 2026 financial results driven by strong performance in its same-store Hospitality segment. The company reported record consolidated revenue of $664.6 million, net income of $69.4 million, and Adjusted EBITDAre of $219.3 million. The hospitality portfolio saw increased boo…
FinWise Bancorp reported Q1 2026 financial results, highlighting $1.7 billion in loan originations, up 38% year-over-year. Net income declined to $2.7 million with diluted EPS of $0.20, compared to previous periods. The quarter saw higher net interest income and margin, driven by growth in credit enhanced loans and strategic programs. However, elev…
Piedmont Realty Trust, a self-managed real estate investment company specializing in Class A office properties in U.S. Sunbelt markets, announced its financial and operational results for Q1 2026. The company has scheduled a conference call and webcast to discuss the quarter's performance and recent developments.
Cue Biopharma has entered an exclusive license agreement to develop and commercialize Ascendant-221, a Phase 2 clinical-stage dual-mechanism anti-IgE monoclonal antibody designed to treat allergic diseases. The company plans a global Phase 2b trial in food allergy after data expected in late 2026 from an ongoing study in chronic spontaneous urticar…
Comstock Inc., a clean energy technology company listed on NYSE American under ticker LODE, will hold its Q1 2026 earnings call and business update webinar on May 7, 2026. The company's CEO and CFO will present financial results and operational updates, followed by a Q&A session. The company focuses on extracting and recycling metals from under-uti…
Alta Equipment Group Inc., a leading North American equipment dealership, announced it will release its first quarter 2026 financial results on May 7 after market close, followed by a management conference call and webcast. The company provides material handling, construction, and environmental processing equipment through over 80 locations across …
CubeSmart reported its Q1 2026 operating results showing largely stable performance with same-store revenue growth turning positive. The company posted diluted EPS of $0.36 and adjusted funds from operations (FFO) per share of $0.63, both slightly down year-over-year. CubeSmart expanded its portfolio by opening a new development property in New Yor…
CooperCompanies, a leading global medical device company, announced it will release its financial results for the second quarter of 2026 on June 4, 2026. The company will host a conference call to discuss results and corporate updates following the release.
Mohawk Industries reported Q1 2026 net earnings of $117 million, with adjusted EPS of $1.90 on $2.7 billion in net sales, an 8% increase reported but a 2.6% decline on constant currency and days. The company benefited from productivity improvements and restructuring efforts, offsetting inflationary cost pressures and volume decreases, while the com…
LXP Industrial Trust has pre-leased its 1.2 million square foot speculative warehouse development in Phoenix to a U.S. subsidiary of a global logistics company, with a five-year lease starting December 2026. The project, costing approximately $122 million, is expected to generate an 8.0% development cash yield, marking a significant leasing milesto…
The Ensign Group, Inc. announced its first quarter 2026 results showing significant growth in earnings and revenue, with GAAP diluted EPS up 21.9% to $1.67 and adjusted EPS rising 21.7% to $1.85. The firm reported increased occupancy and skilled nursing revenue rates, expanded its healthcare operations portfolio with key acquisitions, and raised it…
Westwood Holdings Group, Inc. reported its Q1 2026 results showing growth in assets under management to $18.3 billion, driven by strong performance in Energy and Real Assets strategies and growth in ETFs and private energy secondaries funds. Quarterly revenues totaled $25.0 million, slightly down from the previous quarter but above last year's firs…
Resmed, a leader in health technology focused on sleep and breathing, announced the retirement of longtime CFO Brett Sandercock effective May 4, 2026. Aaron Bloomer, formerly CFO at Exact Sciences, will succeed him. The company reiterated its fiscal 2026 financial outlook, signaling stable operational expectations moving forward.
SI-BONE, Inc., a Nasdaq-listed medical device company specializing in procedural solutions for compromised bone, announced its participation in the 2026 BofA Securities Healthcare Conference with a scheduled fireside chat. The event offers management a platform to discuss company developments and engage with investors.
Aligos Therapeutics, a clinical stage biotechnology company specializing in therapies for liver and viral diseases, announced it will report its first quarter 2026 financial results on May 7, 2026, after the U.S. markets close. The company focuses on developing treatments for chronic hepatitis B, metabolic-associated steatohepatitis, obesity, and c…
Cue Biopharma announces the appointment of Shao-Lee Lin, M.D., Ph.D., as CEO, President, and Board Director to steer the company’s transition into a clinical-stage biopharmaceutical company. Dr. Lin brings over 25 years of experience leading biotech firms and advancing drug candidates. The company is progressing its lead autoimmune candidate, CUE-4…
Syntec Optics Holdings, Inc. successfully closed a $20 million underwritten public offering of 2,857,142 common shares priced at $7.00 each. The company plans to use the proceeds to acquire or invest in complementary businesses, technologies, products or assets, as well as for working capital, capital expenditures, and to optimize its capital struc…
